SCR 76 Hawaii Senate · 2026 Regular Session

REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF MANDATORY HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING.

This bill requests the State Auditor to evaluate the social and financial impacts of a separate law that requires health insurance plans to cover biomarker testing for diagnosing and treating diseases. The assessment will examine how mandating coverage for this type of personalized medical testing affects patients, healthcare providers, and insurance costs. The Auditor must submit a report with findings and recommendations to the Legislature by the start of the 2027 session. This procedural measure ensures the mandated coverage requirement is reviewed before it takes effect, following state law requirements for such health insurance mandates.

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2026

Committee Review

Mar 2026

Senate Passage

Mar 2026

House Passage

Governor

Introduced Mar 16, 2026 Last action Mar 31, 2026

Maddy AI version diff · 1 comparison

What changed between versions

SCR76 → SCR76_SD1 · 3 edits

MINOR

This revision updates the bill's metadata to reflect a change in the primary sponsor from Emma Berman to Fredrick Akau and adjusts the legislative template from a House-specific version to a Senate/HD shared version. The substantive text of the resolution remains largely the same, though minor formatting corrections were made to the 'WHEREAS' clauses regarding biomarker testing coverage requirements.

Scope change

The bill's scope of coverage for biomarker testing remains unchanged; the revision primarily affects administrative metadata and formatting.

TECHNICAL

The primary sponsor was changed from Emma Berman (HCR) to Fredrick Akau (SCR SD or HD), indicating a shift in sponsorship or a correction of the sponsor's designation.

The bill's template was updated from an 'HCR template' to an 'SCR SD/HD template', aligning the document structure with the new sponsor's chamber designation.

Minor text corrections were applied to the 'WHEREAS' clauses, removing redundant words like 'managements' and 'No.' from the bill number citation.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 31, 2026

Upper · Passed

Report adopted, as amended (SD 1) and referred to WAM.

upper

Mar 31, 2026

Committee

Reported from HHS (Stand. Com. Rep. No. 3402), as amended (SD 1), with recommendation of referral to WAM.

upper

Mar 30, 2026

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Keohokalole.

upper

Mar 27, 2026

Upper · Passed

The committee(s) on HHS has scheduled a public hearing on 03-30-26 1:07PM; Conference Room 225 & Videoconference.

upper

Mar 19, 2026

Committee

Referred to HHS, WAM.

upper

Mar 16, 2026

Introduced

Offered.

upper

8 primary · 1 co-sponsor